Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Research Report 2024(Status and Outlook)
Report Overview:
After vaccination, the body can produce a humoral immune response. It is used to prevent infectious diseases caused by group A and group C meningococci, such as cerebrospinal meningitis and pneumonia.
The Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size was estimated at USD 302.30 million in 2023 and is projected to reach USD 426.39 million by 2029, exhibiting a CAGR of 5.90% during the forecast period.
This report provides a deep insight into the global Group A and Group C Meningococcal Polysaccharide Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Group A and Group C Meningococcal Polysaccharide Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Group A and Group C Meningococcal Polysaccharide Vaccine market in any manner.
Global Group A and Group C Meningococcal Polysaccharide Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Walvax
Lanzhou Institute of Biological Products
AIM Bio
Sanofi Pasteur
GSK
Hualan Bio
ZFSW
Changsheng
Kanghua Bio
Market Segmentation (by Type)
Class 1 Vaccine
Class II Vaccine
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Group A and Group C Meningococcal Polysaccharide Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
After vaccination, the body can produce a humoral immune response. It is used to prevent infectious diseases caused by group A and group C meningococci, such as cerebrospinal meningitis and pneumonia.
The Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size was estimated at USD 302.30 million in 2023 and is projected to reach USD 426.39 million by 2029, exhibiting a CAGR of 5.90% during the forecast period.
This report provides a deep insight into the global Group A and Group C Meningococcal Polysaccharide Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Group A and Group C Meningococcal Polysaccharide Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Group A and Group C Meningococcal Polysaccharide Vaccine market in any manner.
Global Group A and Group C Meningococcal Polysaccharide Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Walvax
Lanzhou Institute of Biological Products
AIM Bio
Sanofi Pasteur
GSK
Hualan Bio
ZFSW
Changsheng
Kanghua Bio
Market Segmentation (by Type)
Class 1 Vaccine
Class II Vaccine
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Group A and Group C Meningococcal Polysaccharide Vaccine Market
- Overview of the regional outlook of the Group A and Group C Meningococcal Polysaccharide Vaccine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Group A and Group C Meningococcal Polysaccharide Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Group A and Group C Meningococcal Polysaccharide Vaccine
1.2 Key Market Segments
1.2.1 Group A and Group C Meningococcal Polysaccharide Vaccine Segment by Type
1.2.2 Group A and Group C Meningococcal Polysaccharide Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Sales Sites, Area Served, Product Type
3.6 Group A and Group C Meningococcal Polysaccharide Vaccine Market Competitive Situation and Trends
3.6.1 Group A and Group C Meningococcal Polysaccharide Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Group A and Group C Meningococcal Polysaccharide Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Group A and Group C Meningococcal Polysaccharide Vaccine Price by Type (2019-2024)
7 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Sales by Application (2019-2024)
7.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Growth Rate by Application (2019-2024)
8 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region
8.1.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region
8.1.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Walvax
9.1.1 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
9.1.2 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
9.1.3 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
9.1.4 Walvax Business Overview
9.1.5 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine SWOT Analysis
9.1.6 Walvax Recent Developments
9.2 Lanzhou Institute of Biological Products
9.2.1 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
9.2.2 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
9.2.3 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
9.2.4 Lanzhou Institute of Biological Products Business Overview
9.2.5 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine SWOT Analysis
9.2.6 Lanzhou Institute of Biological Products Recent Developments
9.3 AIM Bio
9.3.1 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
9.3.2 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
9.3.3 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
9.3.4 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine SWOT Analysis
9.3.5 AIM Bio Business Overview
9.3.6 AIM Bio Recent Developments
9.4 Sanofi Pasteur
9.4.1 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
9.4.2 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
9.4.3 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
9.4.4 Sanofi Pasteur Business Overview
9.4.5 Sanofi Pasteur Recent Developments
9.5 GSK
9.5.1 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
9.5.2 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
9.5.3 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
9.5.4 GSK Business Overview
9.5.5 GSK Recent Developments
9.6 Hualan Bio
9.6.1 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
9.6.2 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
9.6.3 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
9.6.4 Hualan Bio Business Overview
9.6.5 Hualan Bio Recent Developments
9.7 ZFSW
9.7.1 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
9.7.2 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
9.7.3 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
9.7.4 ZFSW Business Overview
9.7.5 ZFSW Recent Developments
9.8 Changsheng
9.8.1 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
9.8.2 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
9.8.3 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
9.8.4 Changsheng Business Overview
9.8.5 Changsheng Recent Developments
9.9 Kanghua Bio
9.9.1 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
9.9.2 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
9.9.3 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
9.9.4 Kanghua Bio Business Overview
9.9.5 Kanghua Bio Recent Developments
10 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET FORECAST BY REGION
10.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast
10.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Region
10.2.4 South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Group A and Group C Meningococcal Polysaccharide Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Group A and Group C Meningococcal Polysaccharide Vaccine by Type (2025-2030)
11.1.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Group A and Group C Meningococcal Polysaccharide Vaccine by Type (2025-2030)
11.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Group A and Group C Meningococcal Polysaccharide Vaccine
1.2 Key Market Segments
1.2.1 Group A and Group C Meningococcal Polysaccharide Vaccine Segment by Type
1.2.2 Group A and Group C Meningococcal Polysaccharide Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Sales Sites, Area Served, Product Type
3.6 Group A and Group C Meningococcal Polysaccharide Vaccine Market Competitive Situation and Trends
3.6.1 Group A and Group C Meningococcal Polysaccharide Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Group A and Group C Meningococcal Polysaccharide Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Group A and Group C Meningococcal Polysaccharide Vaccine Price by Type (2019-2024)
7 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Sales by Application (2019-2024)
7.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Growth Rate by Application (2019-2024)
8 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region
8.1.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region
8.1.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Walvax
9.1.1 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
9.1.2 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
9.1.3 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
9.1.4 Walvax Business Overview
9.1.5 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine SWOT Analysis
9.1.6 Walvax Recent Developments
9.2 Lanzhou Institute of Biological Products
9.2.1 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
9.2.2 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
9.2.3 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
9.2.4 Lanzhou Institute of Biological Products Business Overview
9.2.5 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine SWOT Analysis
9.2.6 Lanzhou Institute of Biological Products Recent Developments
9.3 AIM Bio
9.3.1 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
9.3.2 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
9.3.3 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
9.3.4 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine SWOT Analysis
9.3.5 AIM Bio Business Overview
9.3.6 AIM Bio Recent Developments
9.4 Sanofi Pasteur
9.4.1 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
9.4.2 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
9.4.3 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
9.4.4 Sanofi Pasteur Business Overview
9.4.5 Sanofi Pasteur Recent Developments
9.5 GSK
9.5.1 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
9.5.2 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
9.5.3 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
9.5.4 GSK Business Overview
9.5.5 GSK Recent Developments
9.6 Hualan Bio
9.6.1 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
9.6.2 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
9.6.3 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
9.6.4 Hualan Bio Business Overview
9.6.5 Hualan Bio Recent Developments
9.7 ZFSW
9.7.1 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
9.7.2 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
9.7.3 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
9.7.4 ZFSW Business Overview
9.7.5 ZFSW Recent Developments
9.8 Changsheng
9.8.1 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
9.8.2 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
9.8.3 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
9.8.4 Changsheng Business Overview
9.8.5 Changsheng Recent Developments
9.9 Kanghua Bio
9.9.1 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
9.9.2 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
9.9.3 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
9.9.4 Kanghua Bio Business Overview
9.9.5 Kanghua Bio Recent Developments
10 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET FORECAST BY REGION
10.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast
10.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Region
10.2.4 South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Group A and Group C Meningococcal Polysaccharide Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Group A and Group C Meningococcal Polysaccharide Vaccine by Type (2025-2030)
11.1.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Group A and Group C Meningococcal Polysaccharide Vaccine by Type (2025-2030)
11.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Group A and Group C Meningococcal Polysaccharide Vaccine as of 2022)
Table 10. Global Market Group A and Group C Meningococcal Polysaccharide Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Sales Sites and Area Served
Table 12. Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Product Type
Table 13. Global Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Group A and Group C Meningococcal Polysaccharide Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Group A and Group C Meningococcal Polysaccharide Vaccine Market Challenges
Table 22. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Type (Kilotons)
Table 23. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Type (M USD)
Table 24. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Group A and Group C Meningococcal Polysaccharide Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons) by Application
Table 30. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Application
Table 31. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Application (2019-2024)
Table 35. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
Table 44. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 45. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Walvax Business Overview
Table 47. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine SWOT Analysis
Table 48. Walvax Recent Developments
Table 49. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
Table 50. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 51. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Lanzhou Institute of Biological Products Business Overview
Table 53. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine SWOT Analysis
Table 54. Lanzhou Institute of Biological Products Recent Developments
Table 55. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
Table 56. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 57. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine SWOT Analysis
Table 59. AIM Bio Business Overview
Table 60. AIM Bio Recent Developments
Table 61. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
Table 62. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 63. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Sanofi Pasteur Business Overview
Table 65. Sanofi Pasteur Recent Developments
Table 66. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
Table 67. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 68. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. GSK Business Overview
Table 70. GSK Recent Developments
Table 71. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
Table 72. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 73. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Hualan Bio Business Overview
Table 75. Hualan Bio Recent Developments
Table 76. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
Table 77. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 78. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. ZFSW Business Overview
Table 80. ZFSW Recent Developments
Table 81. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
Table 82. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 83. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Changsheng Business Overview
Table 85. Changsheng Recent Developments
Table 86. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
Table 87. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 88. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Kanghua Bio Business Overview
Table 90. Kanghua Bio Recent Developments
Table 91. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 92. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 94. North America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 96. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 98. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 100. South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 104. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Group A and Group C Meningococcal Polysaccharide Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 106. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 107. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Group A and Group C Meningococcal Polysaccharide Vaccine as of 2022)
Table 10. Global Market Group A and Group C Meningococcal Polysaccharide Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Sales Sites and Area Served
Table 12. Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Product Type
Table 13. Global Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Group A and Group C Meningococcal Polysaccharide Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Group A and Group C Meningococcal Polysaccharide Vaccine Market Challenges
Table 22. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Type (Kilotons)
Table 23. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Type (M USD)
Table 24. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Group A and Group C Meningococcal Polysaccharide Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons) by Application
Table 30. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Application
Table 31. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Application (2019-2024)
Table 35. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
Table 44. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 45. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Walvax Business Overview
Table 47. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine SWOT Analysis
Table 48. Walvax Recent Developments
Table 49. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
Table 50. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 51. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Lanzhou Institute of Biological Products Business Overview
Table 53. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine SWOT Analysis
Table 54. Lanzhou Institute of Biological Products Recent Developments
Table 55. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
Table 56. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 57. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine SWOT Analysis
Table 59. AIM Bio Business Overview
Table 60. AIM Bio Recent Developments
Table 61. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
Table 62. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 63. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Sanofi Pasteur Business Overview
Table 65. Sanofi Pasteur Recent Developments
Table 66. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
Table 67. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 68. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. GSK Business Overview
Table 70. GSK Recent Developments
Table 71. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
Table 72. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 73. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Hualan Bio Business Overview
Table 75. Hualan Bio Recent Developments
Table 76. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
Table 77. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 78. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. ZFSW Business Overview
Table 80. ZFSW Recent Developments
Table 81. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
Table 82. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 83. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Changsheng Business Overview
Table 85. Changsheng Recent Developments
Table 86. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Basic Information
Table 87. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 88. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Kanghua Bio Business Overview
Table 90. Kanghua Bio Recent Developments
Table 91. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 92. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 94. North America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 96. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 98. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 100. South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 104. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Group A and Group C Meningococcal Polysaccharide Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 106. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 107. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Group A and Group C Meningococcal Polysaccharide Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country (M USD)
Figure 11. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Group A and Group C Meningococcal Polysaccharide Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Group A and Group C Meningococcal Polysaccharide Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Type
Figure 18. Sales Market Share of Group A and Group C Meningococcal Polysaccharide Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Group A and Group C Meningococcal Polysaccharide Vaccine by Type in 2023
Figure 20. Market Size Share of Group A and Group C Meningococcal Polysaccharide Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Group A and Group C Meningococcal Polysaccharide Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Application
Figure 24. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Application in 2023
Figure 26. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Application (2019-2024)
Figure 27. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Application in 2023
Figure 28. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region in 2023
Figure 44. China Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Group A and Group C Meningococcal Polysaccharide Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country (M USD)
Figure 11. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Group A and Group C Meningococcal Polysaccharide Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Group A and Group C Meningococcal Polysaccharide Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Type
Figure 18. Sales Market Share of Group A and Group C Meningococcal Polysaccharide Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Group A and Group C Meningococcal Polysaccharide Vaccine by Type in 2023
Figure 20. Market Size Share of Group A and Group C Meningococcal Polysaccharide Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Group A and Group C Meningococcal Polysaccharide Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Application
Figure 24. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Application in 2023
Figure 26. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Application (2019-2024)
Figure 27. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Application in 2023
Figure 28. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region in 2023
Figure 44. China Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share Forecast by Application (2025-2030)
